Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 5 Aug 22 424B4 Prospectus supplement with pricing info
- 5 Aug 22 EFFECT Notice of effectiveness
-
2 Aug 22 S-1/A IPO registration (amended)
- 1 Jul 22 S-1 IPO registration
TMBR similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the use of our report dated March 31, 2022, with respect to the consolidated financial statements of Timber Pharmaceuticals, Inc., and subsidiaries, incorporated herein by reference and to the reference to our firm under the heading “Experts” in the prospectus.
/s/ KPMG LLP
Short Hills, New Jersey
July 29, 2022